Skip to main content
Top
Published in: Journal of Neurology 10/2019

01-10-2019 | Parkinson's Disease | Original Communication

Diplopia in Parkinson’s disease: visual illusion or oculomotor impairment?

Authors: Femke Visser, Annemarie M. M. Vlaar, Carlijn D. J. M. Borm, Valentin Apostolov, Y. X. Lee, Irene C. Notting, Henry C. Weinstein, Henk W. Berendse

Published in: Journal of Neurology | Issue 10/2019

Login to get access

Abstract

Introduction

Approximately 20% of patients with Parkinson’s disease (PD) experience diplopia; however, the cause of the diplopia is unclear. We aimed to explore the association of diplopia, and its subtypes, with oculomotor abnormalities, impaired vision, and visual hallucinations, in patients with PD.

Methods

This exploratory study included 41 PD patients, recruited from two general hospitals, of whom 25 had diplopia and 16 did not have diplopia, as well as 23 healthy controls (HCs). We defined subtypes of diplopia as selective diplopia, i.e., diplopia of single objects, and complete diplopia, i.e., diplopia of the entire visual field. All participants underwent a full orthoptic and ophthalmologic examination.

Results

PD patients with diplopia had a high prevalence of oculomotor abnormalities (84%), impaired vision (44%), and visual hallucinations (44%), compared to PD patients without diplopia (33%, 6%, and none, respectively, p < 0.01), and compared to HCs (23%, 9%, and none, respectively, p < 0.01). Oculomotor abnormalities were equally prevalent in both subtypes of diplopia (selective and complete), whereas impaired vision was predominantly found in patients with selective diplopia. Moreover, only patients with selective diplopia had visual hallucinations.

Conclusions

In PD patients, diplopia may be indicative of oculomotor or visual impairments. Hence, it is worthwhile to refer PD patients with diplopia to an orthoptist and an ophthalmologist for evaluation and, possibly, treatment of diplopia. Furthermore, in the case of selective diplopia, the neurologist should consider the presence of visual hallucinations, which may require the adjustment of the patient’s medication.
Literature
1.
go back to reference Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP (2014) Visual complaints and visual hallucinations in Parkinson's disease. Parkinsonism Relat Disord 20:318–322CrossRef Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP (2014) Visual complaints and visual hallucinations in Parkinson's disease. Parkinsonism Relat Disord 20:318–322CrossRef
2.
go back to reference Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629CrossRef Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629CrossRef
3.
go back to reference Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord 26:2387–2395CrossRef Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord 26:2387–2395CrossRef
4.
go back to reference Schindlbeck KA, Schonfeld S, Naumann W, Friedrich DJ, Maier A, Rewitzer C, Klostermann F, Marzinzik F, Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR (2017) Characterization of diplopia in non-demented patients with Parkinson's disease. Parkinsonism Relat Disord 45:1–6CrossRef Schindlbeck KA, Schonfeld S, Naumann W, Friedrich DJ, Maier A, Rewitzer C, Klostermann F, Marzinzik F, Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR (2017) Characterization of diplopia in non-demented patients with Parkinson's disease. Parkinsonism Relat Disord 45:1–6CrossRef
5.
go back to reference Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR (2017) Ocular and visual disorders in Parkinson's disease: common but frequently overlooked. Parkinsonism Relat Disord 40:1–10CrossRef Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR (2017) Ocular and visual disorders in Parkinson's disease: common but frequently overlooked. Parkinsonism Relat Disord 40:1–10CrossRef
6.
go back to reference Nebe A, Ebersbach G (2007) Selective diplopia in Parkinson's disease: a special subtype of visual hallucination? Mov Disord 22:1175–1178CrossRef Nebe A, Ebersbach G (2007) Selective diplopia in Parkinson's disease: a special subtype of visual hallucination? Mov Disord 22:1175–1178CrossRef
7.
go back to reference Diederich NJ, Goetz CG, Stebbins GT (2005) Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 20:130–140CrossRef Diederich NJ, Goetz CG, Stebbins GT (2005) Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 20:130–140CrossRef
8.
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRef
9.
go back to reference Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N (2007) Movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22:41–47CrossRef Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N (2007) Movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22:41–47CrossRef
10.
go back to reference Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649–2653CrossRef Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649–2653CrossRef
11.
go back to reference Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRef Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRef
12.
go back to reference Ansons AM, Davis H (2014) Diagnosis and management of ocular motility disorders, 4th edn. Wiley, West Sussex Ansons AM, Davis H (2014) Diagnosis and management of ocular motility disorders, 4th edn. Wiley, West Sussex
13.
go back to reference Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43–46CrossRef Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43–46CrossRef
14.
go back to reference Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR (2016) Visual dysfunction in Parkinson's disease. Brain 139:2827–2843CrossRef Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR (2016) Visual dysfunction in Parkinson's disease. Brain 139:2827–2843CrossRef
15.
go back to reference Terao Y, Fukuda H, Ugawa Y, Hikosaka O (2013) New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review. Clin Neurophysiol 124:1491–1506CrossRef Terao Y, Fukuda H, Ugawa Y, Hikosaka O (2013) New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review. Clin Neurophysiol 124:1491–1506CrossRef
16.
go back to reference Cullen KE, Van Horn MR (2011) The neural control of fast vs. slow vergence eye movements. Eur J Neurosci 33:2147–2154CrossRef Cullen KE, Van Horn MR (2011) The neural control of fast vs. slow vergence eye movements. Eur J Neurosci 33:2147–2154CrossRef
17.
go back to reference Van Horn MR, Waitzman DM, Cullen KE (2013) Vergence neurons identified in the rostral superior colliculus code smooth eye movements in 3D space. J Neurosci 33:7274–7284CrossRef Van Horn MR, Waitzman DM, Cullen KE (2013) Vergence neurons identified in the rostral superior colliculus code smooth eye movements in 3D space. J Neurosci 33:7274–7284CrossRef
18.
go back to reference Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX (2012) Ocular motor and sensory function in Parkinson's disease. Ophthalmol 119:178–182CrossRef Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX (2012) Ocular motor and sensory function in Parkinson's disease. Ophthalmol 119:178–182CrossRef
19.
go back to reference Chung SD, Ho JD, Hu CC, Lin HC, Sheu JJ (2014) Increased risk of Parkinson disease following a diagnosis of neovascular age-related macular degeneration: a retrospective cohort study. Am J Ophthalmol 157(464–469):e461 Chung SD, Ho JD, Hu CC, Lin HC, Sheu JJ (2014) Increased risk of Parkinson disease following a diagnosis of neovascular age-related macular degeneration: a retrospective cohort study. Am J Ophthalmol 157(464–469):e461
20.
go back to reference Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K (2014) Ophthalmological features of Parkinson disease. Med Sci Monit 20:2243–2249CrossRef Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K (2014) Ophthalmological features of Parkinson disease. Med Sci Monit 20:2243–2249CrossRef
21.
go back to reference Ortuno-Lizaran I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N, Van Horn MR, Waitzman DM, Cullen KE (2018) Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson's disease pathology severity. Mov Disord 33:7274–7284CrossRef Ortuno-Lizaran I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N, Van Horn MR, Waitzman DM, Cullen KE (2018) Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson's disease pathology severity. Mov Disord 33:7274–7284CrossRef
22.
go back to reference Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N (2014) Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects. Neurosci Lett 571:34–38CrossRef Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N (2014) Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects. Neurosci Lett 571:34–38CrossRef
23.
go back to reference Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 31:2473–2475PubMed Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 31:2473–2475PubMed
24.
go back to reference Bodis-Wollner I (2013) Foveal vision is impaired in Parkinson's disease. Parkinsonism Relat Disord 19:1–14CrossRef Bodis-Wollner I (2013) Foveal vision is impaired in Parkinson's disease. Parkinsonism Relat Disord 19:1–14CrossRef
25.
go back to reference Klettner A, Richert E, Kuhlenbaumer G, Nolle B, Bhatia KP, Deuschl G, Roider J, Schneider SA (2016) Alpha synuclein and crystallin expression in human lens in Parkinson's disease. Mov Disord 31:600–601CrossRef Klettner A, Richert E, Kuhlenbaumer G, Nolle B, Bhatia KP, Deuschl G, Roider J, Schneider SA (2016) Alpha synuclein and crystallin expression in human lens in Parkinson's disease. Mov Disord 31:600–601CrossRef
26.
go back to reference Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81–95CrossRef Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81–95CrossRef
27.
go back to reference Lee JY, Kim JM, Ahn J, Kim HJ, Jeon BS, Kim TW (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease. Mov Disord 29:61–67CrossRef Lee JY, Kim JM, Ahn J, Kim HJ, Jeon BS, Kim TW (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease. Mov Disord 29:61–67CrossRef
28.
go back to reference de Maindreville AD, Fenelon G, Mahieux F (2005) Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 20:212–217CrossRef de Maindreville AD, Fenelon G, Mahieux F (2005) Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 20:212–217CrossRef
29.
go back to reference Trieu LH, Lavrich JB (2018) Current concepts in convergence insufficiency. Curr Opin Ophthalmol 29:401–406CrossRef Trieu LH, Lavrich JB (2018) Current concepts in convergence insufficiency. Curr Opin Ophthalmol 29:401–406CrossRef
30.
go back to reference de Silva SR, Evans JR, Kirthi V, Ziaei M, Leyland M (2016) Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev 12:CD003169PubMed de Silva SR, Evans JR, Kirthi V, Ziaei M, Leyland M (2016) Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev 12:CD003169PubMed
31.
go back to reference Nijkamp MD, Dolders MG, de Brabander J, van den Borne B, Hendrikse F, Nuijts RM (2004) Effectiveness of multifocal intraocular lenses to correct presbyopia after cataract surgery: a randomized controlled trial. Ophthalmol 111:1832–1839CrossRef Nijkamp MD, Dolders MG, de Brabander J, van den Borne B, Hendrikse F, Nuijts RM (2004) Effectiveness of multifocal intraocular lenses to correct presbyopia after cataract surgery: a randomized controlled trial. Ophthalmol 111:1832–1839CrossRef
32.
go back to reference Aziz S, Cleary M, Stewart HK, Weir CR (2006) Are orthoptic exercises an effective treatment for convergence and fusion deficiencies? Strabismus 14:183–189CrossRef Aziz S, Cleary M, Stewart HK, Weir CR (2006) Are orthoptic exercises an effective treatment for convergence and fusion deficiencies? Strabismus 14:183–189CrossRef
33.
go back to reference Pershing S, Enns EA, Matesic B, Owens DK, Goldhaber-Fiebert JD (2014) Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med 160:18–29CrossRef Pershing S, Enns EA, Matesic B, Owens DK, Goldhaber-Fiebert JD (2014) Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med 160:18–29CrossRef
34.
go back to reference Ripandelli G, Scarinci F, Piaggi P, Guidi G, Pileri M, Cupo G, Sartini MS, Parisi V, Baldanzellu S, Giusti C, Nardi M, Stirpe M, Lazzeri S (2015) Macular pucker: to peel or not to peel the internal limiting membrane? A microperimetric response. Retina 35:498–507CrossRef Ripandelli G, Scarinci F, Piaggi P, Guidi G, Pileri M, Cupo G, Sartini MS, Parisi V, Baldanzellu S, Giusti C, Nardi M, Stirpe M, Lazzeri S (2015) Macular pucker: to peel or not to peel the internal limiting membrane? A microperimetric response. Retina 35:498–507CrossRef
35.
go back to reference Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson's disease. Lancet Neurol 5:75–86CrossRef Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson's disease. Lancet Neurol 5:75–86CrossRef
Metadata
Title
Diplopia in Parkinson’s disease: visual illusion or oculomotor impairment?
Authors
Femke Visser
Annemarie M. M. Vlaar
Carlijn D. J. M. Borm
Valentin Apostolov
Y. X. Lee
Irene C. Notting
Henry C. Weinstein
Henk W. Berendse
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 10/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09430-w

Other articles of this Issue 10/2019

Journal of Neurology 10/2019 Go to the issue

Letter to the Editors

Hot cross bun sign